Interstitial Lung Disease Diagnosis And Prognosis Using An Ai System Integrating Longitudinal Data

This study was conducted to assess the extent of interstitial lung disease (ILD) in 458 patients enrolled in the Mount Sinai Medical Center Research Registry for Interstitial Lung Disease (MSMC-ILD) between September 2014 and April 2021. The diagnosis of an ILD subtype followed the ATS2018 guidelines and all registry patients had a consensus diagnosis from radiology, pathology, and pulmonology. The patient population age ranged from 22 to 91 years, with 226 males and 223 females. A total of 132 patients (29.4%) were diagnosed with usual interstitial pneumonia (UIP), 37 patients (8.2%) with chronic hypersensitivity pneumonitis (CHP), 142 patients (31.6%) with nonspecific interstitial pneumonia (NSIP), and 138 patients (30.8%) with other ILDs.